---
figid: PMC10472674__11658_2023_484_Fig3_HTML
pmcid: PMC10472674
image_filename: 11658_2023_484_Fig3_HTML.jpg
figure_link: /pmc/articles/PMC10472674/figure/Fig3/
number: Fig. 3
figure_title: ''
caption: 'Inhibition of UGCG expression ameliorated heart hypertrophy and heart fibrosis.
  A–C mRNA levels of ANP, BNP, and β-MHC in hearts from different groups (N = 6).
  D–G Western blot results of Col1, ANP, BNP expression levels in hearts from different
  groups (N = 3). H, J HE staining showed the cell surface area of cardiomyocytes
  from different groups (N = 6). I, K Immunohistochemical images of α-SMA staining
  in heart fibroblasts from different groups (N = 6). L, N Western blot results of
  ANP and BNP expression levels in cardiomyocytes from different groups (N = 3). *p < 0.05.
  AAV-Scramble: Negative control of AAV-Sh-UGCG; Ad-Scramble: Negative control of
  Ad-Sh-UGCG; ANP: Atrial natriuretic peptide; BNP: Brain natriuretic peptide; β-MHC:
  β-myosin heavy chain; Col1: Collagen I; Ad: Adenovirus; TGF-β: Transforming growth factor-beta'
article_title: UGCG modulates heart hypertrophy through B4GalT5-mediated mitochondrial
  oxidative stress and the ERK signaling pathway.
citation: Shengyu Cui, et al. Cell Mol Biol Lett. 2023;28:71.
year: '2023'

doi: ''
journal_title: ''
journal_nlm_ta: ''
publisher_name: ''

keywords:
---
